This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Pharmacyclics Inc (PCYC)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Jun 2012 Jun 2011
Cash and Equivalents 623.96M 307.43M 197.90M 87.76M
Receivables 63.00M 26.70M 6.01M 54.00K
Inventories 12.60M 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 740.80M 346.49M 213.40M 114.70M
Property, Plant & Equipment, Gross 33.19M 14.97M 12.32M 10.20M
Accumulated Depreciation & Depletion 7.72M 8.57M 8.48M 8.89M
Property, Plant & Equipment, Net 25.47M 6.40M 3.84M 1.31M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 2.48M 2.23M 1.88M 344.00K
Total Non-Current Assets 27.95M 8.64M 5.72M 1.66M
Liabilities & Shareholder Equity
Total Assets 768.75M 355.13M 219.12M 116.35M
Accounts Payable 7.41M 4.61M 9.18M 5.68M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 8.49M 1.39M 0.00 0.00
Total Current Liabilities 87.63M 29.26M 18.99M 14.27M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 410.00K
Other Non-Current Liabilities 53.50M 63.35M 68.01M 0.00
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 53.50M 63.35M 68.01M 410.00K
Total Liabilities 141.13M 92.60M 87.00M 14.68M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 627.62M 262.53M 132.12M 101.67M
Common Par 7.00K 7.00K 7.00K 7.00K
Additional Paid In Capital 844.22M 546.13M 533.26M 514.81M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -216.60M -283.61M -401.14M -413.12M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -8.00K -4.00K -9.00K -21.00K
Total Capitalization 627.62M 262.53M 132.12M 101.67M
Total Equity 627.62M 262.53M 132.12M 101.67M
Total Liabilities & Stock Equity 768.75M 355.13M 219.12M 116.35M
Total Common Shares Outstanding 74.17M 70.22M 69.32M 67.92M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 72.78M 69.68M 68.73M 59.97M
Diluted Weighted Shares Outstanding 77.08M 74.41M 72.62M 59.97M
Number of Employees 484 224 150 77
Number of Part-Time Employees 0 0 0 0

PCYC Pharmacyclics Inc

Analysts Ratings for PCYC

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 9 10 10 10
Moderate Buy 0 0 0 0
Hold 5 5 5 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

PCYC Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs